WeightWatchers makes a move into the controversial market for diabetes and obesity drugs including Ozempic
Sequence is a subscription service that offers telehealth visits with doctors who can prescribe the drugs. WeightWatchers, which has long promised to help customers lose weight through food-tracking and lifestyle changes, is moving to also offer customers a medical weight-loss approach.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
WSJ News Exclusive | WeightWatchers Moves Into the Ozempic Market With Telehealth DealThe weight-management company is buying digital health company Sequence, which offers telehealth visits with doctors.
Lire la suite »
WeightWatchers Bets on So-Called Miracle Obesity Drug Ozempic in New Deal: ReportThe Wall Street Journal reported Monday that WeightWatchers is buying a telehealth subscription service called Sequence, which allows doctors to prescribe both Ozempic and its sister drug, Wegovy.
Lire la suite »
WeightWatchers Buying Telehealth Service Known For Ozempic Weight Loss Prescriptions, Report SaysWW’s stock jumped more than 13% in after-hours trading following news of the deal Monday.
Lire la suite »
The Hollywood Weight Loss Wonder DrugOn today’s What Next TBD: When one woman heard about a possible side effect of thyroid tumors, she deadpanned “that seems like a manageable cancer.”
Lire la suite »
New Diabetes Drugs Like Ozempic Are Changing How Patients Are TreatedAfter years recommending generic drug metformin, the American Diabetes Association says doctors could give a newer medicine first.
Lire la suite »
Eating disorder experts are worried about diabetes drugs like Ozempic being used for weight lossThe popularity around weight loss drugs like Ozempic is worrying eating disorder experts, who say the conversation risks making recovery harder and could put others at risk of developing disorders.
Lire la suite »